...
首页> 外文期刊>BMC Health Services Research >Impact of pharmacist-conducted anticoagulation patient education and telephone follow-up on transitions of care: a randomized controlled trial
【24h】

Impact of pharmacist-conducted anticoagulation patient education and telephone follow-up on transitions of care: a randomized controlled trial

机译:药剂师进行的抗凝患者教育和电话随访关注转型的影响:随机对照试验

获取原文
           

摘要

There is limited published data in Lebanon evaluating the impact of supplemental education for anticoagulants use, especially DOACs, on clinical outcomes such as bleeding. The study aims to assess the impact of pharmacist-conducted anticoagulation education and follow-up on bleeding and readmission rates. This study was a randomized, non-blinded interventional study conducted between August 2017 and July 2019 in a tertiary care teaching Lebanese hospital. Participants were inpatients ≥18?years discharged on an oral anticoagulant for treatment. Block randomization was used. The control group received the standard nursing counseling while the intervention group additionally received pharmacy counseling. Phone call follow-ups were done on day 3 and 30 post-discharge. Primary outcomes included readmission rates and any bleeding event at day 3 and 30 post-discharge. Secondary outcomes included documented elements of education in the medical records and reported mortality upon day 30 post-discharge. Two hundred patients were recruited in the study (100 patients in each study arm) with a mean age of 73.9?years. In the pharmacist-counseled group, more patients contacted their physician within 3?days (14% versus 4%; p?=?0.010), received explicit elements of education (p??0.001) and documentation in the chart was better (p??0.05). In the standard of care group, patients were more aware of their next physician appointment date (52% versus 31%, p??0.001). No difference in bleeding rates at day 3 and 30 post-discharge was observed between the groups. Although pharmacist-conducted anticoagulation education did not appear to reduce bleeding or readmission rates at day 30, pharmacist education significantly increased patient communication with their providers in the early days post-discharge. Lebanon Clinical Trial Registry LBCTR2020033424 . Retrospectively registered. Date of registration: 06/03/2020.
机译:黎巴嫩有限的已发布数据,评估补充教育对抗凝血剂使用,特别是DoAC的影响,如出血。该研究旨在评估药剂师进行的抗凝教育和随访对出血和入院率的影响。本研究是2017年8月至2019年7月在黎巴嫩医院的第三次护理教学之间进行的随机非蒙蔽介入研究。参与者是住院患者≥18岁以下的口服抗凝血剂患者进行治疗。使用块随机化。控制组收到标准护理咨询,而干预组另外收到药房咨询。电话后续行动是在第3天和第30天进行后出院后完成。主要结果包括入院率和第3天和后30天的出血事件。二次结果包括记录记录中的教育内容,并在出院后30天报告的死亡率。在研究中招募了两百名患者(每组患者100名患者),平均年龄为73.9岁?年。在药剂师咨询组中,更多患者在3日内联系他们的医师(14%对4%; P?= 0.010),收到明确的教育元素(P?& 0.001)和图表中的文档更好(P?&Δ05)。在护理小组的标准中,患者更加了解他们的下一个医师预约日期(52%,而31%,p?0.001)。在组之间观察到第3天和第30天的出血率没有差异。虽然药剂师进行的抗凝教育在第30天似乎没有减少出血或入院率,但药剂师教育在出院后早期与其提供商的患者沟通显着增加。黎巴嫩临床试验登记处LBCTR2020033424。回顾性地注册。日期(注册):06/03/2020。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号